Clinical trials
Phase 1 Neuromuscular Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adjuvia Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| Cabaletta Bio | 1 |
| Edgewise Therapeutics, Inc. | 1 |
| Johns Hopkins University | 1 |
| PepGen Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromuscular Diseases | 6 |
| Musculoskeletal Diseases | 5 |
| Muscular Diseases | 4 |
| Nervous System Diseases | 4 |
| Genetic Diseases, Inborn | 3 |
| Muscular Disorders, Atrophic | 2 |
| Muscular Dystrophies | 2 |
| Myositis | 2 |
| Arthritis | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.